rs79397275

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003803.4(MYOM1):​c.2802A>G​(p.Pro934Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00212 in 1,608,232 control chromosomes in the GnomAD database, including 86 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 15 hom., cov: 30)
Exomes 𝑓: 0.0020 ( 71 hom. )

Consequence

MYOM1
NM_003803.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.615

Publications

3 publications found
Variant links:
Genes affected
MYOM1 (HGNC:7613): (myomesin 1) The giant protein titin, together with its associated proteins, interconnects the major structure of sarcomeres, the M bands and Z discs. The C-terminal end of the titin string extends into the M line, where it binds tightly to M-band constituents of apparent molecular masses of 190 kD (myomesin 1) and 165 kD (myomesin 2). This protein, myomesin 1, like myomesin 2, titin, and other myofibrillar proteins contains structural modules with strong homology to either fibronectin type III (motif I) or immunoglobulin C2 (motif II) domains. Myomesin 1 and myomesin 2 each have a unique N-terminal region followed by 12 modules of motif I or motif II, in the arrangement II-II-I-I-I-I-I-II-II-II-II-II. The two proteins share 50% sequence identity in this repeat-containing region. The head structure formed by these 2 proteins on one end of the titin string extends into the center of the M band. The integrating structure of the sarcomere arises from muscle-specific members of the superfamily of immunoglobulin-like proteins. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MYOM1 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 18-3126890-T-C is Benign according to our data. Variant chr18-3126890-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416052.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.615 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0621 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYOM1NM_003803.4 linkc.2802A>G p.Pro934Pro synonymous_variant Exon 19 of 38 ENST00000356443.9 NP_003794.3 P52179-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYOM1ENST00000356443.9 linkc.2802A>G p.Pro934Pro synonymous_variant Exon 19 of 38 1 NM_003803.4 ENSP00000348821.4 P52179-1
MYOM1ENST00000261606.11 linkc.2514A>G p.Pro838Pro synonymous_variant Exon 18 of 37 1 ENSP00000261606.7 P52179-2
MYOM1ENST00000582016.1 linkn.358A>G non_coding_transcript_exon_variant Exon 2 of 3 4

Frequencies

GnomAD3 genomes
AF:
0.00296
AC:
451
AN:
152120
Hom.:
15
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000917
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0679
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00545
AC:
1303
AN:
238952
AF XY:
0.00506
show subpopulations
Gnomad AFR exome
AF:
0.000815
Gnomad AMR exome
AF:
0.000513
Gnomad ASJ exome
AF:
0.000102
Gnomad EAS exome
AF:
0.0639
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000537
Gnomad OTH exome
AF:
0.00306
GnomAD4 exome
AF:
0.00203
AC:
2954
AN:
1455994
Hom.:
71
Cov.:
31
AF XY:
0.00201
AC XY:
1453
AN XY:
723628
show subpopulations
African (AFR)
AF:
0.000479
AC:
16
AN:
33422
American (AMR)
AF:
0.000434
AC:
19
AN:
43760
Ashkenazi Jewish (ASJ)
AF:
0.000116
AC:
3
AN:
25970
East Asian (EAS)
AF:
0.0489
AC:
1934
AN:
39586
South Asian (SAS)
AF:
0.00255
AC:
217
AN:
84972
European-Finnish (FIN)
AF:
0.0000752
AC:
4
AN:
53164
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5760
European-Non Finnish (NFE)
AF:
0.000393
AC:
436
AN:
1109124
Other (OTH)
AF:
0.00533
AC:
321
AN:
60236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
127
253
380
506
633
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00297
AC:
452
AN:
152238
Hom.:
15
Cov.:
30
AF XY:
0.00317
AC XY:
236
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.000915
AC:
38
AN:
41552
American (AMR)
AF:
0.00164
AC:
25
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.0679
AC:
352
AN:
5184
South Asian (SAS)
AF:
0.00270
AC:
13
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000250
AC:
17
AN:
68016
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00207
Hom.:
9
Bravo
AF:
0.00309
Asia WGS
AF:
0.0310
AC:
107
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 17, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pro934Pro in exon 19 of MYOM1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 11.0% (22/200) of H an Chinese chromosomes from a broad population by the 1000 Genomes Project (http ://www.ncbi.nlm.nih.gov/projects/SNP; dbSNP rs79397275). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hypertrophic cardiomyopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
4.1
DANN
Benign
0.49
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79397275; hg19: chr18-3126888; COSMIC: COSV107227809; API